Related Experiment Video
Updated: May 27, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Role of renin-angiotensin system in gastric oncogenesis
Mitsushige Sugimoto1, Yoshio Yamaoka, Naohito Shirai
1First Department of Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan. mitsu@hama-med.ac.jp
Abstract:
The renin-angiotensin system (RAS) plays an important role not only in homeostasis but also in carcinogenesis. Recent epidemiological studies suggest that hypertensive patients with upregulated systemic RAS functions are at a significantly increased risk for the subsequent development of cancers with poor outcomes, and moreover that RAS inhibitors reduce tumor development, progression, and metastasis. Notably, Helicobacter pylori infection, one of the major predictors of gastric carcinogenesis, generally leads to RAS component overexpression, as exemplified by that of angiotensin I, angiotensin II, angiotensin I converting enzyme and angiotensin II receptor. Gastric mucosal RAS expression gradually increases with time after H. pylori infection with respect to the severity of inflammatory cell infiltration. Gastric carcinogenic potential is therefore considered to relate to RAS component expression levels and activities. This hypothesis is supported by findings that RAS genotypic variation can lead to high component expression levels (e.g. angiotensin I converting enzyme, chymase and angiotensinogen), and thereby increase the risk of development of gastric cancer. Thus, the RAS may be potently associated with the pathogenesis of H. pylori-related gastric carcinogenesis, and RAS inhibitors may provide tools for specifically preventing this disease.
Insights
The renin-angiotensin system (RAS) is linked to cancer development, particularly in H. pylori-infected stomachs. RAS inhibitors may offer a new strategy for preventing gastric cancer.
Area of Science:
- Oncology
- Cardiovascular Research
- Gastroenterology
Background:
- The renin-angiotensin system (RAS) is crucial for homeostasis and implicated in carcinogenesis.
- Hypertension and upregulated RAS are associated with increased cancer risk and poor outcomes.
- RAS inhibitors have shown potential in reducing tumor development, progression, and metastasis.
Purpose of the Study:
- To investigate the association between Helicobacter pylori infection, RAS component expression, and gastric carcinogenesis.
- To explore the role of RAS in the pathogenesis of H. pylori-related gastric cancer.
- To evaluate the potential of RAS inhibitors in gastric cancer prevention.
Main Methods:
- Review of epidemiological studies linking hypertension, RAS, and cancer risk.
- Analysis of studies on H. pylori infection and its effect on RAS component expression in gastric mucosa.
- Examination of findings on RAS genotypic variations and their relation to gastric cancer risk.
Main Results:
- H. pylori infection leads to overexpression of RAS components (angiotensin I, II, ACE, AT1R) in the gastric mucosa.
- Gastric RAS expression and activity increase with H. pylori infection duration and inflammation severity.
- RAS genotypic variations correlate with higher component expression and increased gastric cancer risk.
Conclusions:
- The RAS is significantly associated with the pathogenesis of H. pylori-related gastric carcinogenesis.
- RAS component expression and activity are key factors in gastric carcinogenic potential.
- RAS inhibitors represent a promising therapeutic strategy for preventing H. pylori-induced gastric cancer.
Related Concept Videos
Hormonal Regulation
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
